AAAAAA

   
Results: 1-3 |
Results: 3
AUTOLOGOUS TRANSPLANTATION (AT) OF CD34-BLOOD PROGENITOR CELLS (PBPC)AFTER DOUBLE (D) HIGH-DOSE CHEMOTHERAPY (HDC) IN MULTIPLE-MYELOMA (MM) IS FOLLOWED BY SEVERE IMMUNODEFICIENCY (ID) AND HIGH PRODUCTION OF INTERLEUKIN-6 (IL-6) RELATED-C REACTIVE PROTEIN (CRP) REQUIRING ADDITIVE IMMUNOTHERAPY (IT)( PERIPHERAL)
Authors: ROSSI JF LEGOUFFE E FEGUEUX N SUN RX EXBRAYAT C LATRY P POLGE G DEVOOS J CAPDEVILA V LU ZY KLEIN B
Citation: Jf. Rossi et al., AUTOLOGOUS TRANSPLANTATION (AT) OF CD34-BLOOD PROGENITOR CELLS (PBPC)AFTER DOUBLE (D) HIGH-DOSE CHEMOTHERAPY (HDC) IN MULTIPLE-MYELOMA (MM) IS FOLLOWED BY SEVERE IMMUNODEFICIENCY (ID) AND HIGH PRODUCTION OF INTERLEUKIN-6 (IL-6) RELATED-C REACTIVE PROTEIN (CRP) REQUIRING ADDITIVE IMMUNOTHERAPY (IT)( PERIPHERAL), Blood, 88(10), 1996, pp. 516-516
RESULT OF RANDOMIZED STUDY COMPARING MELPHALAN-PREDNISONE (MP) TO ALTERNATING MP AND HYDROXYUREA-VAD (VINCRISTINE, ADRIAMYCIN, DEXAMETHASONE, HVAD) IN 148 PATIENTS WITH MULTIPLE-MYELOMA (MM)
Authors: ROSSI JF BOUABDALLAH R FUZIBET JG LEPEU G MARTIN C GRIS JC MARIT G KUGEL C CAPDEVILA V TUBIANA N LEJEUNE C BATAILLE R SOTTO JJ
Citation: Jf. Rossi et al., RESULT OF RANDOMIZED STUDY COMPARING MELPHALAN-PREDNISONE (MP) TO ALTERNATING MP AND HYDROXYUREA-VAD (VINCRISTINE, ADRIAMYCIN, DEXAMETHASONE, HVAD) IN 148 PATIENTS WITH MULTIPLE-MYELOMA (MM), Blood, 86(10), 1995, pp. 735-735
SEQUENTIAL HIGH-DOSE CHEMOTHERAPY (SHDC) SUPPORTED WITH PERIPHERAL-BLOOD STEM-CELL (PBSC) AND LENIGASTRIM (GM-CSF) IN 24 PATIENTS HAVING AGGRESSIVE NON-HODGKINS-LYMPHOMA (ANHL) - CLINICAL AND PHARMACO-ECONOMICANALYSIS
Authors: ROSSI JF LEGOUFFE E PASCAL P VAYSSETTE S BLONDIN C SPORTOUCH MH CAPDEVILA V LU ZY FEGUEUX N HANSEL S KLEIN B
Citation: Jf. Rossi et al., SEQUENTIAL HIGH-DOSE CHEMOTHERAPY (SHDC) SUPPORTED WITH PERIPHERAL-BLOOD STEM-CELL (PBSC) AND LENIGASTRIM (GM-CSF) IN 24 PATIENTS HAVING AGGRESSIVE NON-HODGKINS-LYMPHOMA (ANHL) - CLINICAL AND PHARMACO-ECONOMICANALYSIS, Blood, 86(10), 1995, pp. 3839-3839
Risultati: 1-3 |